CHICAGO (Reuters) - Products used to stimulate bone growth in spinal fusion surgery worsen the risk of complications and boost overall hospital costs, U.S. researchers said on Tuesday. They said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback